These results suggest it is possible that robust deletion of Pdcd1 could enhance short-term functions of CAR T cells but ultimately render edited cells more susceptible to exhaustion/impaired function (for example, if the tumor is not rapidly cleared). Here, PDCD1 is linked to neoplasm.